Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02024867 · ClinicalTrials.gov registry record · NA

Evaluation of 3 Versus 10 Days of Antibiotics in Skin Abscesses After Surgical Drainage

A NA study of Abscess and Skin Disease, Bacterial, sponsored by Lucy Holmes, MD.

Completed
Registry status
NA
Development phase
249
Enrollment target
1
Study location

NCT02024867: Completed NA study of Abscess and Skin Disease, Bacterial, sponsored by Lucy Holmes, MD.

NCT02024867 is a NA study of Abscess and Skin Disease, Bacterial that has completed, run by Lucy Holmes, MD. The registered enrollment target is 249 participants, below the 371-participant average among 13 other Abscess trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02024867, a NA study of Abscess and Skin Disease, Bacterial, has completed, sponsored by Lucy Holmes, MD.

COMPLETED
Registry status
NA
Development phase
249 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to determine if there is a difference in treatment failures and recurrent skin infections when patients are given 3 or 10 days of antibiotics for uncomplicated skin abscesses after they have been surgically drained.

Primary Outcome

Treatment failures were defined as persistent or increased size of the original abscess requiring further medical or surgical intervention. Treatment cure was defined as no or minimal tenderness, erythema, fever, wound drainage, warmth, fluctuance or induration at the 10 to 14 day follow-up.

Interventions

  • DRUG Trimethoprim-Sulfamethoxazole

Study Locations (1)

New York

  • Women & Children's Hospital of Buffalo - Buffalo

Trial Details

FieldValue
Enrollment Target 249 participants
Start Date 2010-02
Est. Completion 2012-07
Phase NA
Lucy Holmes, MD

1 total trials

What the finished NCT02024867 record still lists

NCT02024867 is an interventional study that assigns participants to a tested intervention. The registered 249 participants enrollment target is mid-sized for trials with a published cap, below the 371-participant average among 13 other Abscess trials with a reported enrollment target (33% lower).

The record links to 2 conditions, with Abscess appearing as the primary indexed condition, and to 1 intervention - of which Trimethoprim-Sulfamethoxazole is the first listed.

NCT02024867 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02024867 about?

NCT02024867 is a clinical study titled "Evaluation of 3 Versus 10 Days of Antibiotics in Skin Abscesses After Surgical Drainage". The objective of this study is to determine if there is a difference in treatment failures and recurrent skin infections when patients are given 3 or 10 days of antibiotics for uncomplicated skin abscesses after they have been surgically drained.

What is the current status of trial NCT02024867?

This trial is currently completed. It is a NA study. The enrollment target is 249 participants. The study started on 2010-02. Estimated completion is 2012-07.

What conditions does trial NCT02024867 study?

This clinical trial studies the following conditions: Abscess, Skin Disease, Bacterial.

What interventions are being tested in trial NCT02024867?

The interventions under investigation include: Trimethoprim-Sulfamethoxazole (DRUG).

Who is sponsoring clinical trial NCT02024867?

This trial is sponsored by Lucy Holmes, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02024867 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Abscess

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02024867's enrollment target sits among peer trials

249 5th of 13 higher than 9 of 13 other Abscess trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Abscess trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04628767 · 249 participants · Phase 2

    Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

  • NCT05834907 · 249 participants · NA

    Hands and Hearts Together

  • NCT06067555 · 249 participants · Early Phase 1

    Intradermal Influenza Vaccination

  • NCT06588478 · 249 participants · Phase 2

    A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02024867, the US trial registry maintained by the National Library of Medicine. NCT02024867 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.